miR‐802 inhibits the proliferation, migration, and invasion of CRC cells in vitro and in vivo by inhibiting the expression of the oncogene UBN2, and at the same time enhances the apoptosis of CRC cells.14 Here, UBN2 is linked to colorectal carcinoma.